WWWei Wu

Wei Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei Wu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Chi Liu

    Department of Plastic Surgery Second People's Hospital Shanghai China

    2 shared publications
  • Huichuan Duan

    Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China

    2 shared publications
  • Fanfan Chen

    Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Feng Xie

    Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    1 shared publication
  • Hongwei Zhao

    Department of Dermatology Affiliated Hospital of Liaoning University of Traditional Chinese Medicine Shenyang China

    1 shared publication
  • Liang Xu

    Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China

    1 shared publication

Latest Publications

  • Open Access

    Enhancing Mid‐Upper Facial Contours: Hairline Transplant Solutions for East Asian Women With High and Wide Foreheads

    by Wei Wu, Chi Liu, Peiqi Zhang, Shunuo Zhang, Qian Liu, Meihua Di, Xiaohui Yang, Siyuan Zhu

    Background: A high and wide forehead is a common congenital facial characteristic among East Asian women, often resulting in an imbalanced mid‐upper facial proportion, diminished three‐dimensional contour, and reduced femininity. Although this facial morphology is often congenital, such features frequently lead to appearance‐related anxiety, affecting patients' confidence and social interactions.Objective: This study aimed to investigate how a personalized hairline design strategy using follicular unit extraction (FUE), tailored to East Asian facial proportions, can enhance mid‐upper facial contours in women with high and wide foreheads.Methods: A total of 60 female patients with high and wide foreheads were enrolled, with a mean age of 33.3 ± 7.1 years. Preoperative measurements showed a mean mid‐frontal height of 7.48 ± 0.46 cm and a mean intertemporal width of 14.66 ± 0.65 cm. On average, 3243 ± 1038 follicular units were transplanted at a recipient density of 50–60 FUs/cm2. Postoperative assessments included improvements in forehead contour, naturalness of the hairline, and documentation of adverse events.Results: The average reduction in mid‐frontal height was 1.33 ± 1.10 cm, and the intertemporal width was reduced by 1.47 ± 0.57 cm. On a 5‐point Likert scale, the average satisfaction score for mid‐upper facial contour improvement was 4.70, while the score for the overall hairline appearance was 4.52. Only minor postoperative discomfort was reported, with no severe complications observed.Conclusion: Hair transplantation via FUE is an effective approach for improving mid‐upper facial proportions in East Asian women with high and wide foreheads, resulting in a softer and more three‐dimensional forehead contour. Surgical design based on East Asian facial and hair characteristics yields high patient satisfaction and favorable safety outcomes, supporting its broader clinical application.


  • Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia

    by Chi Liu, Hongwei Zhao, Ying Zhang, Wei Wu

    Background Androgenetic alopecia (AGA) has been one of the most common progressive hair loss in the world, which affects 80% of white males. To date, only minoxidil and finasteride have been approved by FDA for the treatment of AGA. However, limited therapeutic effect and the toxic adverse events of these drugs limit their applications. Therefore, it is still an urgent clinical problem to find effective therapeutic drugs and medication regimen. Objective The goal was to explore the efficacy and side effects of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male patients with early stage of androgenetic alopecia (AGA). Methods Using a randomized control method, 80 male patients with androgenetic alopecia in Hamilton grade II–IV were randomly divided into two groups, with 40 patients in each group. The Group A: 1 ml minoxidil for external use twice a day; Group B: 3500 IU basic fibroblast growth factor (bFGF) and 1 ml minoxidil for external use twice a day. The selected patients received global photograph evaluation before treatment, 3 months after treatment, and 6 months after treatment, and the curative effect was judged according to the changes in the area and degree of hair loss on the top of the head and anterior parietal area of the patients shown in the photographs before and after treatment. At the same time, each patient had a satisfaction questionnaire survey before treatment, 3 months after treatment, and 6 months after treatment. During the research period, the adverse reactions of the patients were recorded. Results After 3 months and 6 months of treatment, the effective rate of the two groups was statistically significant (p < 0.05), and the patients’ hair conditions in the Group B improved significantly compared with those in the Group A. After 6 months of treatment, the difference in treatment satisfaction between the two groups was statistically significant (p < 0.05). The patients in the Group B were more satisfied than those in Group A. During the patient's medication, no serious adverse reactions occurred in the two groups, and the incidence of adverse reactions between the two groups was not statistically significant (p > 0.05). Conclusion Compared with 5% minoxidil alone, the combination of basic fibroblast growth factor (bFGF) +5% minoxidil in the treatment of male patients with early stage of androgenetic alopecia improved treatment efficiency and patient satisfaction.


  • Open Access

    MEF/KSF‑conditioned culture medium: An effective method forin vitroculture of mouse dermal papilla cells with osteogenic differentiation potential

    by Liang Xu, Wenlan Gao, Shanshan Bai, Huichuan Duan, Xiaogang Pan, Wei Wu

    Hair follicle stem cells are pluripotent and have a self‑renewal capacity and multi‑differentiation potential in vitro. As hair follicle stem cells can be easily sampled from the skin and hair of clinical patients at a considerable quantity, these cells have potential applications in wound repair and skin tissue engineering. Effective approaches for the in vitro culture and amplification of mouse hair follicle stem cells, as well as the in vitro osteogenic differentiation potential and cell source when obtaining mouse‑separated cells were examined. Serial subculture was performed in different culture systems. Cell source was detected based on the relevant surface markers derived from mouse hair follicles at the gene and protein levels, and the differential potential was determined. The proliferative ability of hair follicle‑derived stem cells obtained from mouse embryonic fibroblast (MEF)/keratinocyte serum‑free medium (KSF)‑conditioned medium was the highest among all culture systems. The induced group had a stronger osteogenic differentiation potential compared with the non‑induced group, indicating that the cells obtained from MEF/KSF‑conditioned medium were cells derived from the hair follicle dermal papilla. Therefore, the strong osteogenic differentiation potential of the hair follicle‑derived mesenchymal stem cells was screened with MEF/KSF‑conditioned culture medium following amplification, and biological characteristics similar to those of hair follicle dermal papilla cells were observed.

  • Open Access

    Tetrahydroxystilbene Glucoside Effectively Prevents Apoptosis Induced Hair Loss

    by Lulu Chen, Huichuan Duan, Feng Xie, Zhen Gao, Xiaoli Wu, Fanfan Chen, Wei Wu

    The effect of Polygonum multiflorum against hair loss has been widely recognized. 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (TSG) is the main component of Polygonum multiflorum; however, its role in hair regeneration has not been established. To evaluate the hair growth-promoting activity of TSG, depilated C57BL/6J mice were topically treated with normal saline, TSG, Pifithrin-α, Minoxidil for 2 weeks. In this study, we identified that p53, Caspase-3, Active Caspase-3, and Caspase-9 were obviously upregulated in the skin of human and mice with hair loss by western blot analysis. Depilated mice treated with TSG showed markedly hair regrowth. TUNEL+ cells were also reduced in mice with TSG. These changes were accompanied with inhibition of Fas, p53, Bax, Active Caspase-3, and Procaspase-9 activities. These results demonstrated that TSG exerts great hair regrowth effect on hair loss, which was probably mediated by inhibition of p53, Fas, and Bax induced apoptosis.